No abstract

ÖzBu çal›flma, Ni¤de peynirlerinde akar varl›¤›n›n ortaya ç›kar›lmas› ve bölgenin akar enfestasyonu durumunun saptanmas› amac›yla yap›lm›flt›r. Bu amaçla, Haziran-Kas›m 2011 tarihleri aras›nda Ni¤de'den toplam 226 adet peynir (61 adet kaflar ve 165 adet tulum) toplanm›fl ve akar varl›¤› yönünden incelenmifltir. Çal›flma sonucunda incelenen 226 adet peynir numunesinin 2 (%0.88)'sinde Acarus siro varl›¤› tespit edilmifltir. Akarlar›n peynirlerdeki ayl›k prevalans› %0-2 aras›nda belirlenmifltir. Aylara göre A. siro prevalans›, A¤ustos ay›nda %2, Eylül ay›nda %1.85 olarak saptanm›fl buna karfl›l›k çal›flma yap›lan di¤er aylarda enfestasyon tespit edilmemifltir. Sonuç olarak, Ni¤de peynirlerinde akar varl›¤› ilk kez bu çal›flma ile belirlenmifl ve incelenen peynirlerde %0.88 oran›nda akar saptanm›flt›r.Anahtar kelimeler: Akar, Acarus siro, peynir, kaflar, tulum, Ni¤de RESEARCH ON OCCURRENCE OF MITES IN CHEESE CONSUMED IN NIGDE AbstractThe objective of this study is to detect the prevalence of mites in the cheese of Nigde and to determine the rate of the infestation in the region. The study examines the presence of mites in 226 cheese samples (61 Turkish kashar cheese samples and 165 tulum cheese samples) collected between June and November 2011. The results show that mites were detected in 2 (0.88%) out of 226 cheese samples tested. Monthly prevalence of mites was determined as between 0-2% in the cheeses. A prevalence was only detected in August (2%) and September (1.85%), whereas, in the other months infestation was not found. In conclusion, this study is the first one to identify the prevalence of mites in the cheese of Nigde. Also, the rate of mites in the cheese examined was established as 0.88%.

No abstract

Inflammatory bowel disease (IBD) is characterized by many clinical features. Anemia is 1 of the most frequent complications and/or extraintestinal manifestations of IBD. There are conflicting data regarding the relationship between changes in hemoglobin levels and disease prevalence in IBD patients with and without antitumor necrosis factor (antiTNF) therapy. In our study, we aimed to investigate the long-term effect of antiTNF agents on anemia in IBD. The records of IBD patients followed-up in our hospital between January 2011 and January 2021 were reviewed retrospectively. Demographic, clinical, endoscopic, radiological and medical treatment data of the patients were recorded. Complete blood count and laboratory markers of inflammation and disease activation, were recorded at the beginning and at the first year of treatment in all patients. The data of patients with and without antiTNF therapy were analyzed statistically. A total of 240 IBD patients who met the inclusion criteria were enrolled in the study. The number of patients with and without antiTNF therapy was 102 (42.5%) and 138 (57.5%), respectively. The change in all laboratory parameters between the beginning and the first year of treatment was statistically significant (P < .001) in all IBD patients with and without antiTNF therapy. The change in Hb level after 1 year of treatment was significantly different in patients with antiTNF therapy compared to those without therapy (3.00 ± 1.78 g/dL vs 1.19 ± 1.38 g/dL, P < .001). In the multiple regression analysis, male gender, antiTNF therapy, baseline Hb level and iron therapy were independent significant variables of hematopoietic response. This study showed that with appropriate treatment, hemoglobin levels of IBD patients with and without antiTNF therapy increased within 1 year, and the use of antiTNF agents in the treatment of IBD was an independent variable in correcting anemia.

Constipation is a disorder that can result in infrequent defecation, pain, stiffness and difficult stool passage and pathogenesis is multifactorial. A 32-year-old female patient was admitted to family medicine clinic with the complaint of constipation that has been present since childhood. Dyssynergic defecation, which is one of the rare causes of chronic constipation, was detected in the patient whose etiological investigation was carried out. Chronic constipation is a condition that should be evaluated with a detailed medical history, taking into account the risk factors and etiological causes.